10-K: CapForce Inc. Reports Strong Revenue Growth in 2025
Annual Report
CapForce Inc. has reported a significant increase in revenue for the fiscal year ended December 31, 2025, driven by its listing sponsorship services.
Summary
- CapForce Inc. (formerly OpGen, Inc.) has transitioned from a precision medicine company to a financial services and technology firm.
- The company's revenue for the year ended December 31, 2025, increased by 481% to $30.2 million, primarily due to listing sponsorship services.
- This growth was partially offset by a decrease in product sales and laboratory services as legacy operations were scaled down.
- Operating expenses increased by 27% to $6.2 million, mainly due to higher cost of services related to the listing sponsorship business.
- The company secured $0.5 million in financing from AEI Capital Ltd. in 2025, and has access to an additional $6.5 million.
- CapForce Inc. acquired iCapX Sdn. Bhd. in December 2025, a cap table management fintech platform, to expand its service offerings.
- The company's common stock is quoted on the OTC Expert Market, and it is appealing Nasdaq's delisting determination.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this filing as cautiously optimistic, reflecting significant revenue growth from the new business strategy but also highlighting ongoing reliance on related-party financing and market challenges like OTC listing.
Positives
- Significant revenue growth of 481% to $30.2 million in 2025, driven by listing sponsorship services.
- Successful acquisition of iCapX Sdn. Bhd. to enhance fintech capabilities.
- Continued access to financing from AEI Capital Ltd., providing liquidity.
- Strategic shift to the financial services and technology industry appears to be gaining traction with substantial revenue from new services.
- Management believes current cash and access to further financing will support operations for over 12 months.
Negatives
- Legacy operations (product sales and laboratory services) have ceased, with revenues declining by 100%.
- Operating expenses increased by 27% to $6.2 million, outpacing the reduction in R&D, G&A, and S&M expenses from legacy operations.
- The company's common stock is quoted on the OTC Expert Market, indicating limited liquidity and potential for high volatility.
- The company was delisted from Nasdaq and is appealing the decision, indicating potential ongoing regulatory or compliance challenges.
- Significant reliance on a single client for listing sponsorship services in 2025, representing 100% of revenue.
- The company has a history of losses and continues to rely on financing from its controlling stockholder.
Risks
- Failure to effectively manage growth and adapt to market dynamics in the new financial services and technology industry.
- Dependence on evolving and potentially unclear regulatory requirements in the securities and capital markets ecosystem.
- Exposure to economic, political, and regulatory risks in Malaysia and Singapore.
- Potential difficulties in integrating iCapX and realizing anticipated benefits from the acquisition.
- Reliance on data accuracy and performance of advanced computational models.
- Potential for disagreements and limited control in future joint ventures or strategic partnerships.
- Continued reliance on key personnel and the ability to attract and retain skilled employees.
- Concentration of revenues from a single client contract.
- Substantial influence by AEI Capital Ltd. due to its significant ownership stake, potentially leading to conflicts of interest.
- Vulnerability to security breaches, data loss, and system disruptions.
- Potential for systems failures and interruptions in platform availability.
- Counterparty risks where counterparties may fail to meet their obligations.
- Difficulty for investors to buy or sell stock due to the OTC Expert Market listing.
- High volatility of common stock price and potential for loss of investment.
- Dilutive effect from the exercise of outstanding warrants and stock options.
- Potential litigation or government investigations.
- The company's ability to continue as a going concern is dependent on future financing and successful business operations.
Future Outlook
The company anticipates funding its operations primarily through financing arrangements with AEI Capital Ltd. until its operating business can sustain operations or it can monetize its investments in equity securities. The company has the right to sell up to $6.5 million worth of additional shares of common stock to AEI Capital Ltd. until December 31, 2026.
Management Comments
- "We believe that its current cash and its access to additional cash under the August 2024 Securities Purchase Agreement will allow the Company to fund operations in excess of 12 months from the issuance date of its financial statements."
- "The Company is appealing Nasdaqs delisting determination to the SEC. The parties have completed their submissions, and the matter is currently under review by the SEC, but no timetable for a final decision has been indicated."
- "If the Company is unsuccessful with its appeal to the SEC, the Company plans to apply for relisting with The Nasdaq Stock Market LLC after meeting the relevant Nasdaq listing requirements."
Industry Context
StockSavvy.ai notes that CapForce Inc.'s strategic pivot to financial services and technology, specifically listing sponsorship and fintech solutions, aligns with broader industry trends of digitalization and cross-border capital market access, particularly for Asian companies. The company's focus on mid-sized growth-stage companies seeking IPOs between $1 billion and $10 billion market capitalization targets a significant and growing segment of the market, as evidenced by the strong IPO activity in the Asia-Pacific region.
Comparison to Industry Standards
- The Asia-Pacific region accounted for approximately 43% of total IPO proceeds and hosted seven of the world's top 10 IPOs in 2025, indicating a robust market for listing sponsorship services.
- Non-U.S. issuers represented 39.3% of all IPOs on U.S. exchanges in 2025, highlighting the demand for cross-border listing advisory.
- The global financial advisory services market reached approximately $92.76 billion in 2025 and is projected to grow at a CAGR of 6.1% to 6.72% through 2033, indicating a strong market for CapForce's services.
- While major global investment banks dominate high-profile IPOs, CapForce's focus on mid-sized companies and technology-enabled solutions aims to capture an underserved market segment.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Composition | Following the March 2024 Private Placement, a new Board of Directors was appointed, including John Tan Honjian as Chairman and CEO. In August 2024, John Tan Honjian was appointed CEO and Chairman, and new directors Christian-Laurent Bonte, Victor Chua Kok Hoe, Ken Lim Zhao Qi, Ethan Low Yu Jie, and Constance Wong Poh Yin were appointed. | March 2024 - August 2024 | Strengthened board with individuals possessing extensive experience in finance, private equity, and corporate law, aligning with the company's strategic shift. |
| Executive Officer Change | Christian-Laurent Benoit Bonte was appointed Chief Executive Officer, replacing John Tan Honjian. | December 1, 2025 | Transition in leadership to focus on the digital investment banking arm of the company. |
| Director Resignation | Christian-Laurent Benoit Bonte stepped down as a director in connection with his appointment as Head of the Digital Investment Banking Arm. | July 17, 2025 | Streamlined executive focus, with continued involvement in a key operational area. |
| Name Change | Company name changed from OpGen, Inc. to CapForce Inc. | February 27, 2026 | Reflects the company's strategic repositioning and new business focus. |
Legal Proceedings
- The company is appealing Nasdaq's delisting determination to the SEC. The matter is under review by the SEC, with no timetable for a decision.
- The company states it is not party to any claim or litigation that would reasonably be expected to have a material adverse effect on its business.
Related Party Transactions
- The company acquired iCapX Sdn. Bhd. from AEI Capital Ltd., the controlling stockholder, for approximately $12.3 million in shares issued in January 2026.
- CapForce International entered into an Agreement of Assignment of Mandate with AEI Capital Ltd. for listing advisory services, earning $5.0 million in equity in Q4 2024 and $4.0 million in Q2 2025, and $26.0 million in equity and $0.2 million in cash in Q4 2025.
- AEI Capital Ltd. provided financing to the company, with the right to sell up to $9.0 million in common stock, of which $2.0 million was sold in 2024 and $0.5 million in 2025.
- John Tan Honjian, Chairman of CapForce Inc. and CEO of AEI Capital Ltd., is a director of the client for whom listing advisory services were provided, making the client a related party.
Stakeholder Impact
- Shareholders may experience volatility and potential loss of investment due to the company's OTC listing and financial performance.
- Employees are subject to the company's growth and success in the new industry, with compensation including equity incentives.
- The acquisition of iCapX is expected to enhance services for clients in the cap table management and fintech space.
- The company's strategic shift and revenue growth from listing sponsorship services are positive for clients seeking public market access.
Next Steps
- Continue developing the digital investment banking platform, including cross-border securities trading, advanced computational model-enabled investment banking advisory, asset management services, and fintech-enabled capital table management solutions.
- Grow the listing sponsorship and consultancy services business line.
- Pursue relisting on The Nasdaq Stock Market LLC if the appeal to the SEC is unsuccessful and listing requirements are met.
- Continue to leverage the network of AEI Capital Ltd. for client acquisition.
- Develop and strengthen strategic partnerships across Southeast and East Asia.
- Implement a localized digital marketing strategy and thought leadership initiatives.
Key Dates
| Date | Description |
|---|---|
| 2001-01-01 | CapForce Inc. (formerly OpGen, Inc.) was incorporated in Delaware. |
| 2023-11-01 | Company implemented cash management initiatives and restructured U.S. operations. |
| 2024-01-01 | Start of fiscal year 2024. |
| 2024-03-01 | Company entered into a securities purchase agreement with David E. Lazar. |
| 2024-03-25 | Initial closing of the March 2024 Private Placement with David E. Lazar. |
| 2024-04-01 | Assignment of the Company's lease in Rockville, Maryland. |
| 2024-04-17 | Company entered into an employment agreement with David Lazar. |
| 2024-05-01 | Company entered into a securities purchase agreement with a purchaser party. |
| 2024-05-04 | Company entered into a warrant amendment agreement. |
| 2024-05-09 | Company's stockholders approved an amendment to the Certificate of Incorporation and appointed new directors. |
| 2024-05-16 | Company entered into an amendment agreement with the European Investment Bank. |
| 2024-05-20 | Company effected a 1-for-10 reverse stock split. |
| 2024-05-22 | Company filed a certificate of amendment to its Certificate of Incorporation. |
| 2024-06-01 | AEI Capital Ltd. and CapForce International Holdings Ltd. entered into an Agreement of Assignment of Mandate. |
| 2024-06-24 | Company entered into an At the Market Offering Agreement. |
| 2024-07-01 | David E. Lazar resigned as Chief Executive Officer, Chairman, and Director. |
| 2024-07-09 | Company entered into an Amendment and Restatement Agreement with European Investment Bank. |
| 2024-07-13 | Company filed a Current Report on Form 8-K regarding the EIB agreements. |
| 2024-08-01 | All of Curetis assets were sold to Camtech Pte Ltd. |
| 2024-08-01 | All of Ares Genetics assets were sold to bioMerieux S.A. |
| 2024-08-02 | John Tan Honjian was appointed Chief Executive Officer, Chairman, and Director. |
| 2024-08-22 | Company entered into a Securities Purchase Agreement with AEI Capital Ltd. |
| 2024-09-13 | Company submitted its appeal regarding the Nasdaq Hearings Panel's determination. |
| 2024-10-02 | CapForce International Holdings Ltd. entered into an Agreement of Assignment of Mandate with AEI Capital Ltd. |
| 2024-10-03 | Company entered into a First Amendment to the August 2024 Securities Purchase Agreement. |
| 2024-10-09 | Company filed a Current Report on Form 8-K regarding the amendment to the Securities Purchase Agreement. |
| 2024-10-11 | Company entered into a Securities Purchase Agreement with an investor. |
| 2024-10-16 | Company entered into a Warrant Inducement Agreement. |
| 2024-10-26 | Company entered into a Second Amendment Agreement to Warrant Inducement Agreement. |
| 2024-11-01 | Company entered into an agreement to finance its directors and officers insurance policy. |
| 2024-12-01 | Company entered into a Share Sale Agreement with AEI Capital Ltd. to acquire Sun Investment Enterprises Limited. |
| 2024-12-04 | Company entered into consulting agreements with Mohd Azham Azudin and Gillian Tan Rou Yee. |
| 2024-12-06 | Company filed Current Reports on Form 8-K regarding consulting agreements. |
| 2024-12-19 | Nasdaq Listing and Hearing Review Council affirmed the Nasdaq Hearings Panel's decision. |
| 2024-12-23 | David E. Lazar resigned as President of the Company. |
| 2025-01-01 | Start of fiscal year 2025. |
| 2025-01-02 | AEI Capital Ltd. entered into a Letter of Engagement with a Client. |
| 2025-01-09 | Company filed Current Reports on Form 8-K regarding consulting agreements. |
| 2025-01-11 | Company filed a Current Report on Form 8-K regarding a pre-funded warrant. |
| 2025-01-16 | Company filed a Current Report on Form 8-K regarding a share sale agreement. |
| 2025-02-08 | Company filed a Current Report on Form 8-K regarding a warrant amendment. |
| 2025-02-27 | Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation. |
| 2025-03-01 | Company entered into a securities purchase agreement with David E. Lazar. |
| 2025-03-09 | Company entered into a warrant exercise agreement and a letter agreement. |
| 2025-03-29 | Company filed Current Reports on Form 8-K regarding the March 2024 Purchase Agreement and settlement agreements. |
| 2025-04-01 | CapForce International entered into a Joint Venture Agreement with European Credit Investment Bank. |
| 2025-04-17 | Company filed a Current Report on Form 8-K regarding an employment agreement. |
| 2025-04-29 | Company filed a Current Report on Form 8-K regarding a letter agreement. |
| 2025-05-04 | Company filed Current Reports on Form 8-K regarding a securities purchase agreement and warrant amendment. |
| 2025-05-13 | Company filed Current Reports on Form 8-K regarding its Certificate of Incorporation and warrant agreements. |
| 2025-05-14 | Company filed a Current Report on Form 8-K regarding a certificate of amendment. |
| 2025-05-16 | Company filed a Current Report on Form 8-K regarding an amendment agreement with EIB. |
| 2025-05-22 | Company filed a Current Report on Form 8-K regarding a certificate of amendment. |
| 2025-05-29 | Company filed Current Reports on Form 8-K regarding AEI Capital Ltd. agreements. |
| 2025-06-24 | Company filed a Current Report on Form 8-K regarding an At the Market Offering Agreement. |
| 2025-07-05 | Company filed a Current Report on Form 8-K regarding a Standstill Agreement. |
| 2025-08-01 | AEI Capital Ltd. paid the Company $2.45 million for Series E Preferred Stock. |
| 2025-08-08 | Nasdaq filed a Form 25 Notification of Delisting with the SEC. |
| 2025-10-01 | Company entered into an Engagement Agreement. |
| 2025-10-09 | Company filed a Current Report on Form 8-K regarding the amendment to the Securities Purchase Agreement. |
| 2025-10-11 | Company filed a Current Report on Form 8-K regarding a securities purchase agreement. |
| 2025-10-16 | Company filed a Current Report on Form 8-K regarding a warrant inducement agreement. |
| 2025-10-26 | Company filed a Current Report on Form 8-K regarding a warrant amendment agreement. |
| 2025-11-01 | Company entered into an agreement to finance its directors and officers insurance policy. |
| 2025-12-01 | John Tan Honjian resigned as Chief Executive Officer; Christian-Laurent Benoit Bonte was appointed Chief Executive Officer. |
| 2025-12-01 | Company entered into a Share Sale Agreement with AEI Capital Ltd. to acquire Sun Investment Enterprises Limited. |
| 2025-12-03 | Forms 4 for directors and officers were not filed. |
| 2025-12-05 | Company filed Current Reports on Form 8-K regarding offer and promotion letters. |
| 2025-12-11 | A Form 4 for AEI Capital, Ltd. was not filed. |
| 2025-12-17 | Company entered into a Supplement Letter with AEI Capital Ltd. |
| 2025-12-23 | Company filed a Current Report on Form 8-K regarding a supplement letter. |
| 2026-01-01 | Company may sell shares of common stock to AEI Capital Ltd. until December 31, 2026. |
| 2026-01-16 | Company filed a Current Report on Form 8-K regarding a share sale agreement. |
| 2026-02-23 | Company's stockholders approved the 2026 Incentive Compensation Plan and name change. |
| 2026-02-27 | Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation. |
| 2026-05-22 | As of this date, 12,178,278 shares of common stock were outstanding. |
| 2026-05-26 | Date of the Form 10-K filing. |
Recommendation
holdCapForce Inc. has demonstrated significant revenue growth through its strategic pivot to financial services and technology, particularly in listing sponsorship. However, the company's reliance on a single client for its revenue, its OTC listing status, and the ongoing appeal against Nasdaq delisting present considerable risks. While the acquisition of iCapX and the development of a digital investment banking platform show promise, the path to sustained profitability and market stability remains uncertain. Therefore, a 'hold' recommendation is appropriate, advising investors to monitor the company's ability to diversify its client base, achieve Nasdaq relisting, and successfully integrate its new technology offerings.
Keywords
CapForce Inc., SEC Filing, 10-K, Annual Report, Financial Services, Fintech, Listing Sponsorship, Capital Markets, Investment Banking, Cap Table Management, iCapX, AEI Capital Ltd., OTC Markets, Delisting, Revenue Growth
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.